270 related articles for article (PubMed ID: 35503174)
1. Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.
Iqbal J; Al Qarni A; Bakillah A
Adv Exp Med Biol; 2022; 1372():57-65. PubMed ID: 35503174
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
Iqbal J; Walsh MT; Hammad SM; Hussain MM
Trends Endocrinol Metab; 2017 Jul; 28(7):506-518. PubMed ID: 28462811
[TBL] [Abstract][Full Text] [Related]
3. ATP binding cassette family A protein 1 determines hexosylceramide and sphingomyelin levels in human and mouse plasma.
Iqbal J; Walsh MT; Hammad SM; Cuchel M; Rader DJ; Hussain MM
J Lipid Res; 2018 Nov; 59(11):2084-2097. PubMed ID: 30279221
[TBL] [Abstract][Full Text] [Related]
4. Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.
Iqbal J; Walsh MT; Hammad SM; Cuchel M; Tarugi P; Hegele RA; Davidson NO; Rader DJ; Klein RL; Hussain MM
J Biol Chem; 2015 Oct; 290(43):25863-75. PubMed ID: 26350457
[TBL] [Abstract][Full Text] [Related]
5. Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases.
Iqbal J; Jahangir Z; Al-Qarni AA
Adv Exp Med Biol; 2020; 1276():37-52. PubMed ID: 32705593
[TBL] [Abstract][Full Text] [Related]
6. Circulating Sphingolipids and Glucose Homeostasis: An Update.
Ali-Berrada S; Guitton J; Tan-Chen S; Gyulkhandanyan A; Hajduch E; Le Stunff H
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628901
[TBL] [Abstract][Full Text] [Related]
7. ATP-Binding Cassette Transporter Family C Protein 10 Participates in the Synthesis and Efflux of Hexosylceramides in Liver Cells.
Iqbal J; Walsh MT; Hussain MM
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297086
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
Worgall TS
Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipid metabolism and its relationship with cardiovascular, renal and metabolic diseases.
Hernández-Bello F; Franco M; Pérez-Méndez Ó; Donis-Maturano L; Zarco-Olvera G; Bautista-Pérez R
Arch Cardiol Mex; 2023; 93(1):88-95. PubMed ID: 36757794
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins.
Hammad SM; Twal WO; Arif E; Semler AJ; Klein RL; Nihalani D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32045989
[TBL] [Abstract][Full Text] [Related]
12. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid homeostasis in the endoplasmic reticulum and beyond.
Breslow DK
Cold Spring Harb Perspect Biol; 2013 Apr; 5(4):a013326. PubMed ID: 23545423
[TBL] [Abstract][Full Text] [Related]
14. Click reactions with functional sphingolipids.
Fink J; Seibel J
Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
[TBL] [Abstract][Full Text] [Related]
15. Drug Development in the Field of Sphinogolipid Metabolism.
Qu Z; Zhou L
Adv Exp Med Biol; 2022; 1372():169-188. PubMed ID: 35503181
[TBL] [Abstract][Full Text] [Related]
16. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
17. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
Kim JL; Mestre B; Shin SH; Futerman AH
Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins.
Hammad SM; Hunt KJ; Baker NL; Klein RL; Lopes-Virella MF
J Clin Lipidol; 2022; 16(2):173-183. PubMed ID: 35148982
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid signaling in metabolic disorders.
Hla T; Dannenberg AJ
Cell Metab; 2012 Oct; 16(4):420-34. PubMed ID: 22982021
[TBL] [Abstract][Full Text] [Related]
20. Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications.
Hammad SM; Lopes-Virella MF
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
